Dirige, Krissa May B.

HRN: 23-63-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2023
10/16/2023
IV
500mg
Q8H X 7 Doses
S/p LTCS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: